Contemporary management of patients referring to cardiologists one to three years from a myocardial infarction: The EYESHOT Post-MI study

Luca, Leonardo De; Piscione, Federico; Colivicchi, Furio; Lucci, Donata; Mascia, F; Marinoni, Barbara; Cirillo, Plinio; Grosseto, Daniele; Mauro, Ciro; Calabrò, Paolo; Nardi, Federico; Rossini, Roberta; Geraci, Giovanna; Gabrielli, Domenico; Lenarda, Andrea Di; Gulizia, Michele Massimo; Investigators, Eyeshot Post-MI

doi:10.1016/j.ijcard.2018.08.055

Cited by 20 publications

(38 citation statements)

References 19 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…The methods used for the EYESHOT Post‐MI study have been described previously . Briefly, it was a prospective, observational, nationwide registry of consecutive patients with a prior MI managed by cardiologists.…”

Section: Methodsmentioning

confidence: 99%

“…Briefly, it was a prospective, observational, nationwide registry of consecutive patients with a prior MI managed by cardiologists. All patients admitted in cardiology units and/or ambulatory clinics during a period of 3 months with a documented history of presumed spontaneous MI event (non‐ST‐elevation, NSTEMI or ST‐elevation‐MI, STEMI) occurred between 1 and 3 years before enrolment have been included . Patients were enrolled at the beginning of outpatient or day‐hospital visit or at hospital admission.…”

Section: Methodsmentioning

confidence: 99%

“…Data were collected in different periods of consecutive 3 months in each site between 1 March 2017 and 16 December 2017. Over these periods, 1633 consecutive patients [median 22 (IQR 15‐28) months from MI] were enrolled: 1028 (63.0%) presenting to a cardiologist during the second [median 17 (IQR 14‐21) months] and 605 (37.0%) during the third year from MI [median 30 (IQR 27‐33) months] . The study has been carried out in 165 cardiology centers.…”

Section: Methodsmentioning

confidence: 99%

“…The study has been carried out in 165 cardiology centers. Most of the patients were enrolled during outpatient or day‐hospital visits (84%) and the remaining during hospital admissions (16%) …”

Section: Methodsmentioning

confidence: 99%

“…Using data from the EYESHOT (EmploYEd antithrombotic therapies in patients with acute coronary Syndromes HOspitalized in iTaly) Post‐MI study we sought to evaluate the criteria used by cardiologists in daily clinical practice for selecting post‐MI patients eligible for DAPT continuation beyond 1 year.…”

Section: Introductionmentioning

confidence: 99%

See 4 more Smart Citations

How do cardiologists select patients for dual antiplatelet therapy continuation beyond 1 year after a myocardial infarction? Insights from the EYESHOT Post‐MI Study

Luca

Colivicchi

Meessen

et al. 2019

Clinical Cardiology

Self Cite

View full text Add to dashboard Cite

Background Current guidelines suggest to consider dual antiplatelet therapy (DAPT) continuation for longer than 12 months in selected patients with myocardial infarction (MI). Hypothesis We sought to assess the criteria used by cardiologists in daily practice to select patients with a history of MI eligible for DAPT continuation beyond 1 year. Methods We analyzed data from the EYESHOT Post‐MI, a prospective, observational, nationwide study aimed to evaluate the management of patients presenting to cardiologists 1 to 3 years from the last MI event. Results Out of the 1633 post‐MI patients enrolled in the study between March and December 2017, 557 (34.1%) were on DAPT at the time of enrolment, and 450 (27.6%) were prescribed DAPT after cardiologist assessment. At multivariate analyses, a percutaneous coronary intervention (PCI) with multiple stents and the presence of peripheral artery disease (PAD) resulted as independent predictors of DAPT continuation, while atrial fibrillation was the only independent predictor of DAPT interruption for patients both at the second and the third year from MI at enrolment and the time of discharge/end of the visit. Conclusions Risk scores recommended by current guidelines for guiding decisions on DAPT duration are underused and misused in clinical practice. A PCI with multiple stents and a history of PAD resulted as the clinical variables more frequently associated with DAPT continuation beyond 1 year from the index MI.

show abstract

Section: Methodsmentioning

confidence: 99%

Section: Methodsmentioning

confidence: 99%

Section: Methodsmentioning

confidence: 99%

Section: Methodsmentioning

confidence: 99%

Section: Introductionmentioning

confidence: 99%

See 3 more Smart Citations

How do cardiologists select patients for dual antiplatelet therapy continuation beyond 1 year after a myocardial infarction? Insights from the EYESHOT Post‐MI Study

Luca

Colivicchi

Meessen

et al. 2019

Clinical Cardiology

Self Cite

View full text Add to dashboard Cite

show abstract

Established and Emerging Pharmacological Therapies for Post-Myocardial Infarction Patients with Heart Failure: a Review of the Evidence

Luca

2020

Cardiovasc Drugs Ther

View full text Add to dashboard Cite

European Physician Survey Characterizing the Clinical Pathway and Treatment Patterns of Patients Post-Myocardial Infarction

et al. 2022

View full text Add to dashboard Cite

Introduction:The 2019 European Society of Cardiology and European Atherosclerosis Society (2019 ESC/EAS) guidelines stress the importance of managing low-density lipoprotein cholesterol (LDL-C) after myocardial infarction (MI) to reduce the risk of cardiovascular events. Information on guideline implementation is limited. The aim of this survey was to describe current clinical practice regarding LDL-C management in the first year post-MI across Europe, improving understanding of the role of ESC/EAS guidelines on clinical practice. Methods: A qualitative web-based cross-sectional physician survey about the patient pathway and LDL-C management post-MI was conducted in 360 physicians from France, Italy, Germany, The Netherlands, Spain, and the UK (n = 60/country) between December 2019 and June 2020. Secondary and primary care physicians (SCPs/PCPs) described their experiences treating patients post-MI over the preceding 2 months. Results: Physicians reported that on average 90.7% of patients not prescribed lipid-lowering therapy (LLT) before an MI initiated LLT as inpatients; for patients already taking LLT, treatment was intensified for 64.7% of inpatients post-MI. SCPs reported prescribing higher-intensity statins and/or ezetimibe for between 72.3% (Italy) and 88.6% (UK) of patients post-MI. More than 80.0% of SCPs and 51.2% of PCPs stated that they would initiate a change in LLT immediately if patients did not achieve their LDL-C treatment goal by 12 weeks post-MI; 82.0% of SCPs and 55.1% of

show abstract

Contemporary management of patients referring to cardiologists one to three years from a myocardial infarction: The EYESHOT Post-MI study

Cited by 20 publications

References 19 publications

How do cardiologists select patients for dual antiplatelet therapy continuation beyond 1 year after a myocardial infarction? Insights from the EYESHOT Post‐MI Study

How do cardiologists select patients for dual antiplatelet therapy continuation beyond 1 year after a myocardial infarction? Insights from the EYESHOT Post‐MI Study

Established and Emerging Pharmacological Therapies for Post-Myocardial Infarction Patients with Heart Failure: a Review of the Evidence

European Physician Survey Characterizing the Clinical Pathway and Treatment Patterns of Patients Post-Myocardial Infarction

Contact Info

Product

Resources

About